Cormorant Asset Management’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.6M | Buy |
+5,000,000
| New | +$7.6M | 0.57% | 32 |
|
2024
Q2 | – | Sell |
-1,100,000
| Closed | -$18.8M | – | 55 |
|
2024
Q1 | $18.8M | Buy |
+1,100,000
| New | +$18.8M | 0.82% | 34 |
|
2023
Q4 | – | Sell |
-2,879,424
| Closed | -$43.8M | – | 48 |
|
2023
Q3 | $43.8M | Buy |
2,879,424
+657,685
| +30% | +$10M | 2.56% | 12 |
|
2023
Q2 | $28.7M | Buy |
2,221,739
+400,000
| +22% | +$5.16M | 1.61% | 16 |
|
2023
Q1 | $15.1M | Sell |
1,821,739
-150,000
| -8% | -$1.24M | 0.99% | 28 |
|
2022
Q4 | $18.2M | Buy |
1,971,739
+817,315
| +71% | +$7.56M | 1.22% | 28 |
|
2022
Q3 | $750K | Hold |
1,154,424
| – | – | 0.05% | 65 |
|
2022
Q2 | $1.22M | Hold |
1,154,424
| – | – | 0.09% | 66 |
|
2022
Q1 | $2.34M | Hold |
1,154,424
| – | – | 0.18% | 62 |
|
2021
Q4 | $4.38M | Sell |
1,154,424
-457,199
| -28% | -$1.73M | 0.26% | 56 |
|
2021
Q3 | $19.6M | Hold |
1,611,623
| – | – | 0.8% | 36 |
|
2021
Q2 | $13.9M | Sell |
1,611,623
-292,801
| -15% | -$2.52M | 0.47% | 46 |
|
2021
Q1 | $21.1M | Hold |
1,904,424
| – | – | 0.47% | 44 |
|
2020
Q4 | $23.8M | Sell |
1,904,424
-162,878
| -8% | -$2.03M | 0.57% | 38 |
|
2020
Q3 | $22.4M | Sell |
2,067,302
-38,542
| -2% | -$418K | 0.86% | 34 |
|
2020
Q2 | $23.5M | Sell |
2,105,844
-2
| -0% | -$22 | 0.9% | 32 |
|
2020
Q1 | $15.4M | Sell |
2,105,846
-13,286
| -0.6% | -$97K | 0.71% | 35 |
|
2019
Q4 | $29.6M | Buy |
+2,119,132
| New | +$29.6M | 1.18% | 25 |
|